Literature DB >> 1489183

Stability of antimycobacterial drugs in susceptibility testing.

M E Griffith1, H L Bodily.   

Abstract

Aqueous solutions of 0.02% isoniazid, 0.2% streptomycin, 0.2% para-aminosalicylate, and 0.5% ethambutol and ethylene glycol solutions of 0.5% ethionamide stored at 3 to 7 degrees C remained stable for 1 year, as did aqueous solutions of 0.05% ethionamide hydrochloride, 0.05% kanamycin, 0.05% viomycin, and 0.1% capreomycin stored at -20 degrees C. The ethambutol and capreomycin solutions were tested by microbiologic methods; the other solutions were tested by both spectrophotometric and microbiologic methods. Prepared susceptibility testing media made with cycloserine, rifampin, and the above solutions incorporated into Middlebrook 7H10 medium showed acceptable stability when stored at 3 to 7 degrees C for 1 month. During incubation of the test medium at 37 degrees C, approximately half of the activity of isoniazid, ethionamide, ethambutol, cycloserine, and rifampin was lost after periods ranging from 2 to 4 days for ethambutol to 2 weeks for rifampin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489183      PMCID: PMC284342          DOI: 10.1128/AAC.36.11.2398

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1963 Feb-Mar

2.  Bacteriology of tuberculosis: laboratory methods.

Authors:  G MIDDLEBROOK; M L COHN
Journal:  Am J Public Health Nations Health       Date:  1958-07

3.  Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing.

Authors:  L S Guthertz; M E Griffith; E G Ford; J M Janda; T F Midura
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  Stability of antibiotics and chemotherapeutics in agar plates.

Authors:  K J Ryan; G M Needham; C L Dunsmoor; J C Sherris
Journal:  Appl Microbiol       Date:  1970-09

5.  A simple biological method for determination of small amounts of tuberculostatic agents in fluids.

Authors:  K D Stottmeier; C L Woodley; G P Kubica; R E Beam
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  5 in total
  11 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin.

Authors:  J A Dijkstra; T van der Laan; O W Akkerman; M S Bolhuis; W C M de Lange; J G W Kosterink; T S van der Werf; J W C Alffenaar; D van Soolingen
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 3.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

4.  Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro.

Authors:  E D Pieterman; M J Sarink; C Sala; S T Cole; J E M de Steenwinkel; H I Bax
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

5.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  Rifampin stability in 7H9 broth and Löwenstein-Jensen medium.

Authors:  Xia Yu; Guanglu Jiang; Huiwen Li; Yanlin Zhao; Hongtao Zhang; Liping Zhao; Yu Ma; Christopher Coulter; Hairong Huang
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

7.  Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.

Authors:  Anna Engström; Nora Morcillo; Belen Imperiale; Sven E Hoffner; Pontus Juréen
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

8.  Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.

Authors:  Cynthia A Sanders; Rachel R Nieda; Edward P Desmond
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

9.  Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations.

Authors:  Hoang Anh Nguyen; Olivier Denis; Anne Vergison; Paul M Tulkens; Marc J Struelens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains.

Authors:  Jeffrey M Chen; Swapna Uplekar; Stephen V Gordon; Stewart T Cole
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.